SCHEDULE: Manulife Amends Veeco Instruments Stake

Manulife Financial Corporation and its subsidiaries updated their beneficial ownership of Veeco Instruments Inc. common stock, with Manulife Investment Management (US) LLC holding 5.55%.

Summary

• Manulife Financial Corporation, Manulife Investment Management Limited, and Manulife Investment Management (US) LLC filed an Amendment No. 2 to their Schedule 13G for Veeco Instruments Inc.
• Manulife Investment Management (US) LLC beneficially owns 3,340,116 shares of Veeco Instruments Inc. common stock, representing 5.55% of the class.
• Manulife Investment Management Limited beneficially owns 19,183 shares, representing 0.03% of the class.
• Manulife Financial Corporation is deemed to have beneficial ownership of these shares through its parent-subsidiary relationship with Manulife Investment Management (US) LLC and Manulife Investment Management Limited.
• The total number of common shares outstanding for Veeco Instruments Inc. was 60,161,823 as of July 31, 2025, according to the issuer's Form 10-Q filed on August 8, 2025.
• Manulife Investment Management (US) LLC and Manulife Investment Management Limited each hold sole voting and sole dispositive power over their respective beneficially owned shares.

Sentiment

Score: 5

Explanation: This is a neutral, factual filing about beneficial ownership. It neither indicates positive nor negative developments for the issuer or the reporting entities, but rather a routine regulatory update.

Positives

• No explicit positives are directly stated in this beneficial ownership disclosure.

Negatives

• No explicit negatives are directly stated in this beneficial ownership disclosure.

Risks

• No specific risks related to Veeco Instruments Inc. or the reporting persons are mentioned in this beneficial ownership filing.

Future Outlook

This filing is a factual report of beneficial ownership and does not contain forward-looking statements or guidance regarding the issuer's or reporting persons' future outlook, beyond the future dates on the document itself.

Management Comments

• No specific management comments or notable quotes are provided in this beneficial ownership filing.

Industry Context

This filing reflects a routine disclosure by an institutional investor regarding its passive ownership stake in a publicly traded company. It does not provide specific insights into broader industry trends for Veeco Instruments Inc. or the investment management sector, beyond Manulife's continued investment in the company.

Comparison to Industry Standards

• This filing is a standard regulatory disclosure of beneficial ownership by an institutional investor. It does not contain performance metrics or operational results that would allow for a direct comparison to industry benchmarks or specific comparable companies/projects.
• The ownership percentage of 5.55% by Manulife Investment Management (US) LLC represents a significant institutional stake in Veeco Instruments Inc., consistent with typical portfolio allocations by large asset managers.

Stakeholder Impact

• This filing primarily impacts shareholders of Veeco Instruments Inc. by providing transparency on significant institutional ownership.
• It confirms Manulife's continued investment, which can be viewed as a vote of confidence by a major financial institution in the company's long-term prospects.

Next Steps

• No specific future actions, events, or milestones are mentioned in this beneficial ownership filing.

Key Dates

Recommendation

This Schedule 13G/A filing is a routine disclosure of beneficial ownership by Manulife Financial Corporation and its subsidiaries in Veeco Instruments Inc. It indicates that Manulife Investment Management (US) LLC holds a 5.55% stake. While this confirms a significant institutional presence, the filing itself does not provide new financial performance data, strategic updates, or changes in investment intent that would warrant a change in investment recommendation. It is a transparency update on an existing position, thus a 'hold' recommendation is appropriate as it doesn't alter the fundamental investment thesis based solely on this document.

Keywords

Veeco Instruments Inc., Manulife Financial Corporation, Manulife Investment Management, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing